Research Article

Simultaneous Quantification of Aspirin, Its Metabolite Salicylic Acid, and Salvianolic Acid B in Human Plasma Using UPLC-MS/MS

Table 7

Mean of pharmacokinetic parameters of Sal B in the SV group and A + S group and SA in AP group and A + S group (mean ± SD%).

ParameterSal BSA
SV group (n = 5)A + S group (n = 5)AP group (n = 6)A + S group (n = 5)

Tmax (h)1.6 ± 0.11.6 ± 0.17.3 ± 3.05.6 ± 2.2
Cmax (μg/mL)2.3 ± 1.81.1 ± 0.53.3 ± 1.12.8 ± 1.0
T1/2 (h)4.4 ± 1.57.3 ± 5.32.6 ± 0.82.8 ± 0.8
AUC0-t (h × μg/mL)3.5 ± 1.91.9 ± 0.824 ± 7.519 ± 8.9
AUC0-∞ (h × μg/mL)3.6 ± 2.02.1 ± 0.924 ± 7.320 ± 9.0

Tmax: time point of maximum plasma concentration; Cmax: maximum plasma concentration; T1/2: half-life of drug elimination during the terminal phase; AUC0-t: area under the plasma concentration-time curve from zero hours to last time point; and AUC0-∞: area under the plasma concentration-time curve from zero hours to infinity.